Sanofi (ADR)

NYSE: SNY
$43.72
-$0.97 (-2.2%)
Closing price March 31, 2020
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine to deal with this novel coronavirus and where they stand now.
Chris Lange
U.S. consumer confidence continues to decline, but the slide has slowed. On Sunday, the FDA and the Department of Health and Human Services okayed two drugs for use in the fight against COVID-19.
Paul Ausick
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine, treatment or test to deal with this coronavirus and here is where their stocks stand now.
Chris Lange
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine, treatment or test to deal with this novel coronavirus. Here's how they fared as the week wound down.
Chris Lange
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine to deal with this novel coronavirus and where they stand now.
Chris Lange
Wednesday's top analyst upgrades, downgrades and initiations included Accenture, Anheuser-Busch InBev, Cerner, CNOOC, Delta Air Lines, Ford, GoDaddy, Kinder Morgan, Newmont, NuStar, United Airlines...
Jon C. Ogg
Wednesday's top analyst upgrades, downgrades and initiations included AECOM, Albermarle, Apple, Chesapeake Energy, Foot Locker, Gap, GoPro, Nike, Qualcomm, Southwest Airlines, Under Armour and...
Jon C. Ogg
After Lexicon Pharmaceuticals announced the termination of its alliance with Sanofi, its shares rallied on Wednesday.
Chris Lange
The U.S. FDA has recalled more than 2,000 medical devices used to keep contamination out of drug delivery systems such as IV lines.
Paul Ausick
The U.S. FDA periodically releases alerts on existing medical products that have been recalled or for which health care providers have been notified of some issues related to a product. Here are all...
Paul Ausick
Here, 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and U.S. Food and Drug Administration (FDA) updates in February and March.
Chris Lange
The included top analyst upgrades, downgrades and initiations seen on Tuesday Apptio, AT&T, Bain Capital, Comerica, First Solar, Palo Alto Networks, Pfizer, Travelers and Ulta Beauty.
Jon C. Ogg
The top analyst upgrades, downgrades and initiations seen on Thursday included American Eagle Outfitters, Facebook, Nutrisystem, Pfizer, Roku, SeaWorld, Valero Energy and Zynga.
Jon C. Ogg
2018 has been a strange time for investors. While the U.S. stock market sits close to all-time highs, many of the emerging and other developed markets nations have seen their shares take a beating....
Jon C. Ogg
The more recent observations about Buffett's portfolio changes coming into mid-2018 have been quite different than many of the historic and traditional Buffett picks.
Jon C. Ogg